Mycoplasma pneumonia medical therapy
|
Mycoplasma pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mycoplasma pneumonia medical therapy On the Web |
|
American Roentgen Ray Society Images of Mycoplasma pneumonia medical therapy |
|
Risk calculators and risk factors for Mycoplasma pneumonia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Antimicrobial therapy is the mainstay for atypical pneumonia caused by mycoplasma. Pharmacologic therapies for mycoplasma pneumonia include either macrolides, Doxycycline, and second generation Quinolones. Supportive therapy includes either nonsteroidal anti-inflammatory drugs (NSAIDS) or Acetaminophen. Aspirin should be avoided in children.
Medical Therapy
Antimicrobial Regimen
-
- Preferred regimen (1): Azithromycin 500 mg PO qd on day 1 and 250 mg PO qd on days 2 to 5
- Preferred regimen (2): Clarithromycin 500 mg PO qd for 14 days
- Preferred regimen (3): Moxifloxacin 400 mg PO qd for 14 days
- Preferred regimen (4): Levofloxacin 750 mg PO qd for 14 days
- Alternative regimen : Doxycycline 100 mg PO bid for 14 days
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.